Johnson Jeh C. 4
4 · METLIFE INC · Filed Jun 11, 2026
Research Summary
AI-generated summary of this filing
MetLife (MET) Director Jeh C. Johnson Receives 61 Shares
What Happened Jeh C. Johnson, a director of MetLife, received 61 shares on 2026-06-09 at an imputed price of $85.57 per share, totaling roughly $5,220. The transaction is recorded as an award/acquisition (A) and reflects an imputed reinvestment of dividends rather than an open-market purchase.
Key Details
- Transaction date and price: 2026-06-09 at $85.57 per share (total ≈ $5,220).
- Shares owned after transaction: Not specified in the Form 4 filing.
- Footnote: Imputed reinvestment of dividends on deferred shares under the MetLife Deferred Compensation Plan for Non-Management Directors (deferred shares are payable shares the director has elected to defer).
- Filing timeliness: Form filed 2026-06-11 for the 2026-06-09 transaction (appears timely per SEC Form 4 rules).
Context This was a routine dividend reinvestment into deferred director compensation, not an open-market buy or sale. Such awards reflect plan mechanics (reinvesting dividends into deferred share balances) and do not necessarily indicate director trading sentiment.
Insider Transaction Report
Form 4
METLIFE INCMET
Johnson Jeh C.
Director
Transactions
- Award
Common Stock
[F1]2026-06-09$85.57/sh+61$5,220→ 8,911 total
Footnotes (1)
- [F1]Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.
Signature
/s/ Morgan Keehner-Jones Mayes, Attorney-in-fact|2026-06-11